Clinical Trial Update: Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the effectiveness and safety of Lebrikizumab for moderate-to-severe atopic dermatitis in adults and adolescents; the trial is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Atopic Dermatitis, Eczema | Phase 3 | Status: ACTIVE_NOT_RECRUITING